Banner University Medical Center, Phoenix, Arizona; Stanford Health Care, Stanford, California.
Mercy Medical Group, Dignity Health Heart & Vascular Institute, Sacramento, California.
Heart Rhythm. 2018 Sep;15(9):1348-1355. doi: 10.1016/j.hrthm.2018.04.021. Epub 2018 Apr 20.
Since the evaluation of the cryoballoon in the Sustained Treatment Of Paroxysmal Atrial Fibrillation trial, more than 350,000 patients with atrial fibrillation have been treated. Several studies have reported improved outcomes using the second-generation cryoballoon, and recent publications have evaluated modifications, refinements, and improvements in procedural techniques. Here, peer-reviewed articles published since the first cryoballoon best practices review were summarized against the technical practices of physicians with a high level of experience with the cryoballoon (average ≥6 years of experience in ≥900 cases). This summary includes a comprehensive literature review along with practical usage guidance from physicians using the cryoballoon to facilitate safe, efficient, and effective outcomes for patients with atrial fibrillation.
自《冷冻球囊治疗阵发性心房颤动的持续性治疗试验》（Sustained Treatment Of Paroxysmal Atrial Fibrillation trial）评估以来，已有超过 35 万名心房颤动患者接受了治疗。多项研究报告称，使用第二代冷冻球囊可改善治疗效果，最近的出版物评估了手术技术的改进、完善和提高。在这里，对自第一次冷冻球囊最佳实践审查以来发表的同行评议文章进行了总结，这些文章针对具有冷冻球囊丰富经验的医生的技术实践（平均≥6 年经验，≥900 例）。该总结包括全面的文献综述，以及使用冷冻球囊的医生的实际使用指南，以促进心房颤动患者的安全、有效和有效的治疗效果。
